All News

As part of the final rule, MTM programs must include an annual comprehensive medication review, targeted medication review, and patient visit summaries.

Findings from a Mayo Clinic case study suggest that Botox may offer relief to patients with disabling low cerebrospinal fluid headaches.

Do you support making significant cuts in Medicare and Medicaid in order to reduce the national deficit?

New data suggest that altering gut bacteria may be the key to providing relief for IBS, a disorder that continues to perplex both pharmacists and patients.

A new study finds that the greatest risk factor for an adverse drug reaction is the number of new medications that have been added to a patient's regimen.

Was the recent FDA ruling on preterm labor drug Makena a victory for compounding pharmacy?

The Internal Revenue Service has its eye on the wealthiest taxpayers. Find out the most common tax return "red flags" that will trigger an audit.

Pharmacy Times launched a new site that's both an educational resource and meeting place for busy pharmacists.

Pharmacists should take careful note of handling guidelines for Boehringer Ingelheim's new blood thinner Pradaxa.

Even minor treatment delays can prolong hospitalization for pediatric patients with bacterial pneumonia.

Faced with unprecedented drug shortages, many providers are paying sky-high prices for substitute drugs

A new partnership between APhA and LearnSomething aims to simplify how pharmacists comply with the FDA's educational requirements for REMS.

With pharmacists struggling to find jobs, is opening another pharmacy school a wise choice?

What pharmacists need to know now about this standardization and how it affects the industry.

Pharmacists can collaborate with oncologists to maximize patient outcomes through appropriate dispensing, side-effect monitoring, and adherence.

What each stakeholder needs to know about REMS in today's fast-paced climate.

Several posters presented the American Pain Society Annual Meeting focused on risk evaluation and mitigation strategies.

Pharmacists can provide vaccinations and help patients choose OTC products to provide symptomatic relief from the flu.

Patients require pharmacists' expert help to get symptomatic relief.

Confusing guidelines regarding dosing of some OTC products can potentially harm young children.

Cold season gives pharmacists an opportunity to correct misconceptions patients have about the common cold.

The symptoms and severity of migraines affect people differently, which can make treatment a challenge.

Most of the 30 million Americans suffering with migraines don't get adequate relief from their current medications, according to a recent survey.

Aspirin is an alternative to ibuprofen or acetaminophen for the temporary self-treatment of migraine, according to a new review.

As health care reform brings The Medical Home concept closer to reality, what can pharmacists expect?

Will medication therapy management become a routine part of most dispensing pharmacists' activities, or will a select group of pharmacists handle this role?

Utilizing a properly executed medication therapy management program will promote increased adherence to treatment among with patients with asthma.

Jeff Schiff, MD, MBA, examines the risk factors that need to be considered in a risk-adjusted medical home reimbursement strategy.